OZONE PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
OZONE PHARMA
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
-
2023 · -€52+€52
Equity
-€733
2023 · -€733
Cash
-
not filed
Balance sheet total
€378
2023 · €4,861-€4,483
Largest movements
Assets
- Receivables within one year -€4,475
down €4,475 (-92.2%), from €4,853 to €378
Equity and liabilities
- Other debts -€4,483
down €4,483 (-80.1%), from €5,594 to €1,111
Income statement
- Financial charges -€52
no longer reported in 2024 (was €52)
From the 2023 result to the 2024 result
The net result is not in both sets of accounts; without it the difference cannot be explained line by line.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,861 | €378 | -€4,483 | -92.2% |
| Current assets | 29/58 | €4,861 | €378 | -€4,483 | -92.2% |
| Amounts receivable within one year | 40/41 | €4,853 | €378 | -€4,475 | -92.2% |
| Other amounts receivable | 41 | €4,853 | €378 | -€4,475 | -92.2% |
| Current investments | 50/53 | €8 | - | -€8 | |
| Total equity and liabilities | 10/49 | €4,861 | €378 | -€4,483 | -92.2% |
| Equity | 10/15 | -€733 | -€733 | = | 0.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€19,333 | -€19,333 | = | 0.0% |
| Amounts payable | 17/49 | €5,594 | €1,111 | -€4,483 | -80.1% |
| Amounts payable within one year | 42/48 | €5,594 | €1,111 | -€4,483 | -80.1% |
| Other amounts payable | 47/48 | €5,594 | €1,111 | -€4,483 | -80.1% |
| Financial charges | 65/66B | €52 | - | -€52 | |
| Recurring financial charges | 65 | €52 | - | -€52 | |
| Profit (loss) for the period before taxes | 9903 | -€52 | - | +€52 | |
| Profit (loss) for the period | 9904 | -€52 | - | +€52 | |
| Profit (loss) for the period to be appropriated | 9905 | -€52 | - | +€52 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.